Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Preventive Effect of a Novel Recombinant sTNFRII on Collagen-Induced Arthritis.

Luo M, Zhao A, Gao H, He L, Guo Y, Tian D, Liu Y, Chen L, Liu P, Hu Z, Gao J.

Immunol Invest. 2015;44(5):470-81. doi: 10.3109/08820139.2015.1030758.

PMID:
26107746
2.

Protective effects of a novel trimerized sTNFRII on acute liver injury.

Luo M, Liu D, Zhang L, Huang S, Yang W, Zhang L, Cui T, Ma H, Wang Z, Sun Q, Xiong C, Zhu J, Li J, Wu X, Jin L, Hu Z, Gao J.

Int Immunopharmacol. 2012 May;13(1):88-92. doi: 10.1016/j.intimp.2012.03.013. Epub 2012 Mar 30.

PMID:
22465962
3.

Kirenol exerts a potent anti-arthritic effect in collagen-induced arthritis by modifying the T cells balance.

Lu Y, Xiao J, Wu ZW, Wang ZM, Hu J, Fu HZ, Chen YY, Qian RQ.

Phytomedicine. 2012 Jul 15;19(10):882-9. doi: 10.1016/j.phymed.2012.04.010. Epub 2012 Jun 4.

PMID:
22673798
4.

Selective tumor necrosis factor receptor I blockade is antiinflammatory and reveals immunoregulatory role of tumor necrosis factor receptor II in collagen-induced arthritis.

McCann FE, Perocheau DP, Ruspi G, Blazek K, Davies ML, Feldmann M, Dean JL, Stoop AA, Williams RO.

Arthritis Rheumatol. 2014 Oct;66(10):2728-38. doi: 10.1002/art.38755.

5.
6.

Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.

Joosten LA, Lubberts E, Helsen MM, Saxne T, Coenen-de Roo CJ, Heinegård D, van den Berg WB.

Arthritis Res. 1999;1(1):81-91. Epub 1999 Oct 26.

7.
8.

Protective effects of Huang-Lian-Jie-Du-Tang and its component group on collagen-induced arthritis in rats.

Hu Y, Hu Z, Wang S, Dong X, Xiao C, Jiang M, Lv A, Zhang W, Liu R.

J Ethnopharmacol. 2013 Dec 12;150(3):1137-44. doi: 10.1016/j.jep.2013.10.038. Epub 2013 Nov 7.

PMID:
24212076
9.

Comparison of drug and cell-based delivery: engineered adult mesenchymal stem cells expressing soluble tumor necrosis factor receptor II prevent arthritis in mouse and rat animal models.

Liu LN, Wang G, Hendricks K, Lee K, Bohnlein E, Junker U, Mosca JD.

Stem Cells Transl Med. 2013 May;2(5):362-75. doi: 10.5966/sctm.2012-0135. Epub 2013 Apr 16.

10.

RANKL inhibition by osteoprotegerin prevents bone loss without affecting local or systemic inflammation parameters in two rat arthritis models: comparison with anti-TNFalpha or anti-IL-1 therapies.

Stolina M, Schett G, Dwyer D, Vonderfecht S, Middleton S, Duryea D, Pacheco E, Van G, Bolon B, Feige U, Zack D, Kostenuik P.

Arthritis Res Ther. 2009;11(6):R187. doi: 10.1186/ar2879. Epub 2009 Dec 11.

11.

Acute liver injury attenuation of a novel recombinant sTNFR through blocking hepatic apoptosis.

Luo M, Zhao A, Li J, Chen Y, Tian D, Wang C, Hu Z, Gao J.

Immunopharmacol Immunotoxicol. 2015 Jun;37(3):295-300. doi: 10.3109/08923973.2015.1035390. Epub 2015 May 18.

PMID:
25982795
12.

Anti-inflammatory effect of quetiapine on collagen-induced arthritis of mouse.

Kim H, Bang J, Chang HW, Kim JY, Park KU, Kim SH, Lee KJ, Cho CH, Hwang I, Park SD, Ha E, Jung SW.

Eur J Pharmacol. 2012 Mar 5;678(1-3):55-60. doi: 10.1016/j.ejphar.2011.12.017. Epub 2011 Dec 23.

PMID:
22209881
13.

Influence of polysaccharide fractions isolated from Caltha palustris L. on the cellular immune response in collagen-induced arthritis (CIA) in mice. A comparison with methotrexate.

Suszko A, Obmińska-Mrukowicz B.

J Ethnopharmacol. 2013 Jan 9;145(1):109-17. doi: 10.1016/j.jep.2012.10.038. Epub 2012 Nov 1.

PMID:
23123796
14.

Anti-inflammatory effects of recombinant human PDCD5 (rhPDCD5) in a rat collagen-induced model of arthritis.

Xiao J, Li G, Hu J, Qu L, Ma D, Chen Y.

Inflammation. 2015 Feb;38(1):70-8. doi: 10.1007/s10753-014-0008-x.

15.

Efficient production of sTNFRII-gAD fusion protein in large quantity by use of the modified CHO-S cell expression system.

Cai Q, Zhao A, Yuting Yin, Ma L, Jiao Z, Zhi H, Lai S, Cheng S, Yang H, Lu Y, Siminovitch KA, Gao J.

PLoS One. 2014 Oct 23;9(10):e111229. doi: 10.1371/journal.pone.0111229. eCollection 2014.

16.

[Inhibition of cartilage destruction in collagen-induced arthritis by altered CII 263-272 peptide: experiment with rats].

Yao ZQ, Zhao JX, Li R, Li ZG.

Zhonghua Yi Xue Za Zhi. 2006 Nov 21;86(43):3055-8. Chinese.

PMID:
17288836
17.

T-614, a novel immunomodulator, attenuates joint inflammation and articular damage in collagen-induced arthritis.

Du F, Lü LJ, Fu Q, Dai M, Teng JL, Fan W, Chen SL, Ye P, Shen N, Huang XF, Qian J, Bao CD.

Arthritis Res Ther. 2008;10(6):R136. doi: 10.1186/ar2554. Epub 2008 Nov 19.

18.

Construction of an anti-IL-1β scfv and TNFRI fusion protein and its therapeutic effect on RA mice model.

Kan F, Ren G, Guo M, Qi J, Zhang Y, Han Y, Zhang Y, Li D.

Curr Pharm Biotechnol. 2014;14(12):1048-61.

PMID:
24433504
20.

Torilin ameliorates type II collagen-induced arthritis in mouse model of rheumatoid arthritis.

Endale M, Lee WM, Kwak YS, Kim NM, Kim BK, Kim SH, Cho J, Kim S, Park SC, Yun BS, Ko D, Rhee M.

Int Immunopharmacol. 2013 Jun;16(2):232-42. doi: 10.1016/j.intimp.2013.04.012. Epub 2013 Apr 24.

PMID:
23623942

Supplemental Content

Support Center